125 related articles for article (PubMed ID: 10476049)
1. Galectin-3 and galectin-3-binding site expression in human adult astrocytic tumours and related angiogenesis.
Gordower L; Decaestecker C; Kacem Y; Lemmers A; Gusman J; Burchert M; Danguy A; Gabius H; Salmon I; Kiss R; Camby I
Neuropathol Appl Neurobiol; 1999 Aug; 25(4):319-30. PubMed ID: 10476049
[TBL] [Abstract][Full Text] [Related]
2. Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration.
Camby I; Belot N; Rorive S; Lefranc F; Maurage CA; Lahm H; Kaltner H; Hadari Y; Ruchoux MM; Brotchi J; Zick Y; Salmon I; Gabius HJ; Kiss R
Brain Pathol; 2001 Jan; 11(1):12-26. PubMed ID: 11145198
[TBL] [Abstract][Full Text] [Related]
3. Secreted protein, acidic and rich in cysteine (SPARC) expression in astrocytic tumour cells negatively correlates with proliferation, while vascular SPARC expression is associated with patient survival.
Capper D; Mittelbronn M; Goeppert B; Meyermann R; Schittenhelm J
Neuropathol Appl Neurobiol; 2010 Apr; 36(3):183-97. PubMed ID: 20132490
[TBL] [Abstract][Full Text] [Related]
4. Galectin fingerprinting in tumor diagnosis. Differential expression of galectin-3 and galectin-3 binding sites, but not galectin-1, in benign vs malignant uterine smooth muscle tumors.
Schwarz G; Remmelink M; Decaestecker C; Gielen I; Budel V; Burchert M; Darro F; Danguy A; Gabius HJ; Salmon I; Kiss R
Am J Clin Pathol; 1999 May; 111(5):623-31. PubMed ID: 10230352
[TBL] [Abstract][Full Text] [Related]
5. Correlation of aquaporin-1 water channel protein expression with tumor angiogenesis in human astrocytoma.
El Hindy N; Bankfalvi A; Herring A; Adamzik M; Lambertz N; Zhu Y; Siffert W; Sure U; Sandalcioglu IE
Anticancer Res; 2013 Feb; 33(2):609-13. PubMed ID: 23393355
[TBL] [Abstract][Full Text] [Related]
6. Expression and distribution of id helix-loop-helix proteins in human astrocytic tumors.
Vandeputte DA; Troost D; Leenstra S; Ijlst-Keizers H; Ramkema M; Bosch DA; Baas F; Das NK; Aronica E
Glia; 2002 Jun; 38(4):329-38. PubMed ID: 12007145
[TBL] [Abstract][Full Text] [Related]
7. Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system.
Bresalier RS; Yan PS; Byrd JC; Lotan R; Raz A
Cancer; 1997 Aug; 80(4):776-87. PubMed ID: 9264362
[TBL] [Abstract][Full Text] [Related]
8. Expression of tenascin-C in astrocytic tumors: its relevance to proliferation and angiogenesis.
Kim CH; Bak KH; Kim YS; Kim JM; Ko Y; Oh SJ; Kim KM; Hong EK
Surg Neurol; 2000 Sep; 54(3):235-40. PubMed ID: 11118570
[TBL] [Abstract][Full Text] [Related]
9. The levels of expression of galectin-1, galectin-3, and the Thomsen-Friedenreich antigen and their binding sites decrease as clinical aggressiveness increases in head and neck cancers.
Choufani G; Nagy N; Saussez S; Marchant H; Bisschop P; Burchert M; Danguy A; Louryan S; Salmon I; Gabius HJ; Kiss R; Hassid S
Cancer; 1999 Dec; 86(11):2353-63. PubMed ID: 10590378
[TBL] [Abstract][Full Text] [Related]
10. Galectin-1 and galectin-3 binding pattern expression in renal cell carcinomas.
François C; van Velthoven R; De Lathouwer O; Moreno C; Peltier A; Kaltner H; Salmon I; Gabius HJ; Danguy A; Decaestecker C; Kiss R
Am J Clin Pathol; 1999 Aug; 112(2):194-203. PubMed ID: 10439799
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of cyclin A in astrocytic tumours.
Chakrabarty A; Bridges LR
Neuropathol Appl Neurobiol; 1998 Jun; 24(3):239-45. PubMed ID: 9717190
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of tumour vessels in cytological squash smears of astrocytic tumours.
Sato S; Sato Y; Marutsuka K; Takeshima H; Asada Y
Cytopathology; 2011 Oct; 22(5):313-7. PubMed ID: 21039979
[TBL] [Abstract][Full Text] [Related]
13. Expression of c-Met correlates with grade of malignancy in human astrocytic tumours: an immunohistochemical study.
Nabeshima K; Shimao Y; Sato S; Kataoka H; Moriyama T; Kawano H; Wakisaka S; Koono M
Histopathology; 1997 Nov; 31(5):436-43. PubMed ID: 9416484
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of S100 calcium-binding proteins characterizes distinct clinical entities in both WHO grade II and III astrocytic tumours.
Camby I; Lefranc F; Titeca G; Neuci S; Fastrez M; Dedecken L; Schäfer BW; Brotchi J; Heizmann CW; Pochet R; Salmon I; Kiss R; Decaestecker C
Neuropathol Appl Neurobiol; 2000 Feb; 26(1):76-90. PubMed ID: 10736069
[TBL] [Abstract][Full Text] [Related]
15. Proliferating cell nuclear antigen expression in the survival of astrocytoma patients.
Ang LC; Plewes M; Tan L; Begley H; Agranovich A; Shul D
Can J Neurol Sci; 1994 Nov; 21(4):306-10. PubMed ID: 7874614
[TBL] [Abstract][Full Text] [Related]
16. Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyma.
Rorive S; Belot N; Decaestecker C; Lefranc F; Gordower L; Micik S; Maurage CA; Kaltner H; Ruchoux MM; Danguy A; Gabius HJ; Salmon I; Kiss R; Camby I
Glia; 2001 Mar; 33(3):241-55. PubMed ID: 11241742
[TBL] [Abstract][Full Text] [Related]
17. Angiogenic patterns and their quantitation in high grade astrocytic tumors.
Sharma S; Sharma MC; Gupta DK; Sarkar C
J Neurooncol; 2006 Aug; 79(1):19-30. PubMed ID: 16807783
[TBL] [Abstract][Full Text] [Related]
18. Correlation of galectin-3/galectin-3-binding sites with low differentiation status in head and neck squamous cell carcinomas.
Delorge S; Saussez S; Pelc P; Devroede B; Marchant H; Burchert M; Zeng FY; Danguy A; Salmon I; Gabius HJ; Kiss R; Hassid S
Otolaryngol Head Neck Surg; 2000 Jun; 122(6):834-41. PubMed ID: 10828795
[TBL] [Abstract][Full Text] [Related]
19. Galectin-3 expression in human breast carcinoma: correlation with cancer histologic grade.
Idikio H
Int J Oncol; 1998 Jun; 12(6):1287-90. PubMed ID: 9592187
[TBL] [Abstract][Full Text] [Related]
20. Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor.
Nagy N; Bronckart Y; Camby I; Legendre H; Lahm H; Kaltner H; Hadari Y; Van Ham P; Yeaton P; Pector JC; Zick Y; Salmon I; Danguy A; Kiss R; Gabius HJ
Gut; 2002 Mar; 50(3):392-401. PubMed ID: 11839721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
